In conclusion, the present study showed that miR-139-5p is downregulated in colorectal cancer cells and tissues, and its inhibitory effects on cell migration, invasion, and drug sensitivity are mediated by the downregulation of its target BCL2. Here, BCL2 is linked to colorectal cancer.